VOLORIDGE INVESTMENT MANAGEMENT, LLC - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.7%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$679,000
-26.8%
44,846
-63.8%
0.00%
-20.0%
Q2 2022$928,000
-56.5%
123,766
-47.2%
0.01%
-58.3%
Q1 2022$2,135,000
-9.7%
234,625
-30.3%
0.01%
-7.7%
Q4 2021$2,365,000
+156.8%
336,833
+316.7%
0.01%
+116.7%
Q3 2021$921,000
-60.2%
80,828
-44.1%
0.01%
-62.5%
Q2 2021$2,313,000
-8.7%
144,472
+1.9%
0.02%
-11.1%
Q1 2021$2,533,000
+21.0%
141,732
-8.5%
0.02%0.0%
Q4 2020$2,093,000
-13.3%
154,942
-24.5%
0.02%
-10.0%
Q3 2020$2,415,000
+62.2%
205,170
+103.4%
0.02%
+17.6%
Q2 2020$1,489,000
+254.5%
100,888
+361.3%
0.02%
+142.9%
Q3 2019$420,000
+11.4%
21,870
+71.4%
0.01%
-30.0%
Q2 2019$377,000
-90.2%
12,760
-82.5%
0.01%
-89.5%
Q2 2017$3,833,000
+1385.7%
72,947
+968.5%
0.10%
+1483.3%
Q4 2016$258,000
-84.1%
6,827
-84.1%
0.01%
-82.9%
Q3 2016$1,623,00043,0070.04%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders